Predicting the risk for dialysis or death in IgA nephropathy. - Wikidata - awgldk - TriplyDB

Predicting the risk for dialysis or death in IgA nephropathy.

Predicting the risk for dialysis or death in IgA nephropathy.

http://www.wikidata.org/entity/Q34726899

about

Predicting progression of IgA nephropathy: new clinical progression risk score.Association of C4d deposition with clinical outcomes in IgA nephropathy.Optimal proteinuria target for renoprotection in patients with IgA nephropathy.Time-averaged albumin predicts the long-term prognosis of IgA nephropathy patients who achieved remission.Corticosteroid therapy in IgA nephropathy.Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments Chronic kidney disease prediction is an inexact science: The concept of "progressors" and "nonprogressors"Mortality of IgA nephropathy patients: a single center experience over 30 years Efficacy and safety of mycophenolate mofetil treatment in IgA nephropathy: a systematic review Review of cases of IgA nephropathy.Validation of the absolute renal risk of dialysis/death in adults with IgA nephropathy secondary to Henoch-Schönlein purpura: a monocentric cohort study.Tacrolimus decreases albuminuria in patients with IgA nephropathy and normal blood pressure: a double-blind randomized controlled trial of efficacy of tacrolimus on IgA nephropathy.Mapping novel immunogenic epitopes in IgA nephropathy Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD.Predicting mortality in older adults with kidney disease: a pragmatic prediction model Mycophenolate mofetil therapy for steroid-resistant IgA nephropathy with the nephrotic syndrome in children Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.Macrophage migration inhibitory factor urinary excretion revisited – MIF a potent predictor of the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis Association of Relapse with Renal Outcomes under the Current Therapy Regimen for IgA Nephropathy: A Multi-Center Study.Urine podocyte mRNAs mark disease activity in IgA nephropathy.FGF23, albuminuria, and disease progression in patients with chronic IgA nephropathy Proteinuria during Follow-Up Period and Long-Term Renal Survival of Childhood IgA Nephropathy Vitamin D deficiency may predict a poorer outcome of IgA nephropathy Autoantibodies targeting galactose-deficient IgA1 associate with progression of IgA nephropathy The level of galactose-deficient IgA1 in the sera of patients with IgA nephropathy is associated with disease progression Long-term outcomes of IgA nephropathy presenting with minimal or no proteinuria Ambulatory blood pressure and tubulointerstitial injury in patients with IgA nephropathy Update on immunoglobulin a nephropathy. Part II: Clinical, diagnostic and therapeutical aspects.Tonsillectomy reduces recurrence of IgA nephropathy in mesangial hypercellularity type categorized by the Oxford classification.The predictive value of attenuated proteinuria at 1 year after steroid therapy for renal survival in patients with IgA nephropathy IgA nephropathy in a laboratory worker that progressed to end-stage renal disease: a case report S-Fas urinary excretion helps to predict the immunosuppressive treatment outcomes in patients with proliferative primary glomerulonephritis.Plasma endocan level and prognosis of immunoglobulin A nephropathy.Development and validation of a prediction rule using the Oxford classification in IgA nephropathy.Pathogenesis of immunoglobulin A nephropathy: recent insight from genetic studies.Progression of IgA nephropathy under current therapy regimen in a Chinese population.Glomerular diseases: emerging tests and therapies for IgA nephropathy Decreased Serum C3 Levels in Immunoglobulin A (IgA) Nephropathy with Chronic Kidney Disease: A Propensity Score Matching Study.Novel biomarkers in glomerular disease.Clinical outcomes of IgA nephropathy patients with different proportions of crescents.

P2860

Q31068314-CC8C0CE3-AE4B-43B2-AB27-93753935FA2C Q33571848-A636A0B1-A943-4893-9BF5-A40CB4192AEC Q33864287-2C598AE2-44F9-4379-8C56-71275DF25958 Q33906377-D8274234-7873-49D1-BEC5-CD9BC2422956 Q34249313-23ACF59A-9F5D-4E0B-BB82-02451AAF4B22 Q34284540-B91615B1-5094-4B7F-8ACF-7B3EC68F2BEB Q34367656-AA808DE6-1464-454D-AF31-789F85E4A196 Q34506767-69987579-C91A-48B5-84C0-E22F001AD3B9 Q34709848-FD7D6DEC-C66C-471A-8E71-C2E7FDE6557E Q34747324-4BF693BB-3ACB-4BE2-A96B-C023950D42C5 Q34893531-9272C41F-266A-4BC0-B212-3A9E1AC6A8E8 Q34971424-216B7F77-FE83-4BE1-841F-CD218A7F4ED0 Q35144385-FAC899B2-6FFD-4AFE-802C-E782B760FF22 Q35144410-30692D6E-7DC2-42AA-A9C0-F678C50B26F0 Q35217850-3DED3EDD-BB74-49C0-8A78-DB9DFB14B3C9 Q35657080-3286463E-7D3E-4F2F-8CBE-258AA20C7503 Q35692544-767E9675-DFC1-49B4-A627-D3BA941F3FFC Q35745565-63AA97F5-E628-4F26-8372-1AB2CEE8A9CE Q35775659-8006D1F1-04A3-43CA-AE4F-AF6330E7FB11 Q35777614-F7CD677C-DCF4-4E7F-83A9-A27EFE7F11FF Q35917428-E2926355-194C-4612-8BAC-06012082EB08 Q35957866-797E9135-D20F-454E-97FD-CD4C0A0AE0F0 Q36180594-877BF98A-786E-448E-9259-2B92463EF587 Q36200922-6B31D9FB-0167-4043-99B8-41BD3E24A966 Q36237466-4E88FA84-7407-455F-A628-6105B5D5575C Q36280349-37287837-5EE4-4639-8C66-76E450B4BE30 Q36306742-5B11C95C-4170-4923-8255-8FDBB2B28B19 Q36447934-456E8433-9ECA-4E27-AFBE-A4E882E496EE Q36963938-FD015046-6AAE-481D-86BA-F5B17619CF50 Q37115267-ED41646E-58FC-41BA-9DC9-798296FD025B Q37157798-F0BDE668-D256-469B-AE1B-610C02C7F970 Q37220474-EACA1E75-5236-4B8A-A28E-AABE0C1517FB Q37260183-9CD26BF3-2D32-4A87-A20D-181E4CD37032 Q37359051-BA870824-87AF-47A0-828D-5EBE2088E79E Q37578868-A8D95EBB-A969-4D48-B176-A610809CA7BE Q37621529-12AE951F-294C-4D6D-828A-6C6CBE0B1444 Q37621563-99DAE370-3E61-4A3F-9E76-BA2F8213967C Q37643259-CF8EB69D-707B-472B-99A1-C8D7A6B480A8 Q37658483-5BC24AD0-AD69-45BD-9388-34CAD6E23848 Q37725286-55AEA3A6-835B-48EE-9B7B-C01C6C0F23C6

P2860

Predicting the risk for dialysis or death in IgA nephropathy.

http://www.wikidata.org/entity/Q34726899

description

2011 nî lūn-bûn

@nan

2011 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Predicting the risk for dialysis or death in IgA nephropathy.

@ast

Predicting the risk for dialysis or death in IgA nephropathy.

@en

Predicting the risk for dialysis or death in IgA nephropathy.

@nl

type

label

Predicting the risk for dialysis or death in IgA nephropathy.

@ast

Predicting the risk for dialysis or death in IgA nephropathy.

@en

Predicting the risk for dialysis or death in IgA nephropathy.

@nl

prefLabel

Predicting the risk for dialysis or death in IgA nephropathy.

@ast

Predicting the risk for dialysis or death in IgA nephropathy.

@en

Predicting the risk for dialysis or death in IgA nephropathy.

@nl

P1433

Q34726899-C57BD682-F153-457B-AF61-1187A559F665

P1476

Q34726899-C4EC18D2-B4A3-4E53-ADF2-FB0267B0D5D9

P2093

Q34726899-12BF5A61-C107-471C-868C-088B2206609E

Q34726899-2148DEA6-DA24-47A2-AD18-6409144F071C

Q34726899-21963110-99E7-44FF-B2BD-11DB3CEF7E38

Q34726899-51D3AADA-FB7F-4DE2-8F44-6CB83D45B830

Q34726899-F4F9A717-E023-4B92-93B5-14AF72D14765

Q34726899-F5A10CD6-62AB-4485-9D0D-19BD57349933

P2860

Q34726899-00A82135-9021-482F-A558-B86C73EF4881

Q34726899-14546825-2EAB-4FBF-985D-21B3EC0D3092

Q34726899-17EBEE60-FD3E-4C29-9FF6-FEC705377988

Q34726899-1A052A7B-499F-4040-9955-3A2F4EC2C898

Q34726899-212B2E23-A51B-4E8C-B6D2-FAB27BD35132

Q34726899-23600212-CCDF-469D-A4BF-576B911D9E14

Q34726899-253307D1-210A-474C-A3A2-66ACF08461C1

Q34726899-34E70E3E-2AB0-4C62-BC84-BABD9A3C6BC6

Q34726899-3A6A2D45-0022-4E31-87FF-BDA9B4AC7682

Q34726899-3D069879-D1D9-495D-9A8D-9C5722A1A309

P304

Q34726899-C779DA1A-2FCC-404D-A6CA-E1502ED9A5A7

P31

Q34726899-8FE6AF69-4EE5-4BA5-8A4D-1B72E6585220

P356

Q34726899-1DED8E04-C517-4520-B126-87D1AFFBA223

P433

Q34726899-0D2F7161-F4F8-4686-AE7D-3E25CC3B6631

P478

Q34726899-E7BFAE5F-CE0D-4830-843B-2A01A474C7B5

P577

Q34726899-EF517849-C85F-410B-BA4F-235E15B465CD

P698

Q34726899-4411DF0E-A4C0-4D72-B8B6-AD17284BC52A

P921

Q34726899-77431C0C-C5B4-47C8-9F04-367720D10A8C

P932

Q34726899-6783A785-203C-42DD-A15D-BDAEFCA0C2D9

P356

P1433

Journal of the American Society of Nephrology

P1476

Predicting the risk for dialysis or death in IgA nephropathy.

@en

P2093

Aida Afiani

http://www.w3.org/2001/XMLSchema#string

Blandine Laurent

http://www.w3.org/2001/XMLSchema#string

Christophe Mariat

http://www.w3.org/2001/XMLSchema#string

François Berthoux

http://www.w3.org/2001/XMLSchema#string

Hesham Mohey

http://www.w3.org/2001/XMLSchema#string

Lise Thibaudin

http://www.w3.org/2001/XMLSchema#string

P2860

Natural history of primary IgA nephropathy

General cardiovascular risk profile for use in primary care: the Framingham Heart Study

Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.

Histopathologic features aid in predicting risk for progression of IgA nephropathy

Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors.

Predicting progression in IgA nephropathy.

The Oxford classification of IgA nephropathy: pathology definitions, correlations, and reproducibility.

The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for IgA nephropathy.

Risk stratification for progression of IgA nephropathy using a decision tree induction algorithm.

P304

752-761

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1681/ASN.2010040355

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P577

2011-01-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21258035

http://www.w3.org/2001/XMLSchema#string

P921

P932

3065230

http://www.w3.org/2001/XMLSchema#string